AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective dropped by analysts at Needham & Company LLC from $46.00 to $40.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. Needham & Company LLC’s price objective points to a potential upside of […]
AtriCure (NASDAQ:ATRC – Get Free Report) had its target price cut by Canaccord Genuity Group from $57.00 to $49.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s price target would indicate a potential upside of 134.56% from the stock’s […]
AtriCure (NASDAQ:ATRC – Get Free Report) had its price target decreased by research analysts at JPMorgan Chase & Co. from $42.00 to $34.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the medical device company’s stock. JPMorgan Chase & Co.‘s price target would indicate a potential […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) insider Justin J. Noznesky sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $24.09, for a total transaction of $36,135.00. Following the completion of the transaction, the insider now directly owns 71,284 shares in […]
AtriCure (NASDAQ:ATRC) Stock Price Down 5 5% After Insider Selling theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.